SmartNuclide

company

About

SmartNuclide is a biopharmaceutical company that develops biological drug products.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
¥10M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Sep 25, 2015
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥33M
SmartNuclide has raised a total of ¥33M in funding over 2 rounds. Their latest funding was raised on Apr 23, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 23, 2020 Series B ¥20M 2 Ruihe Zichan Detail
Feb 2, 2018 Series A ¥10M 2 Detail
Mar 21, 2016 Angel ¥3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
5
SmartNuclide is funded by 5 investors. Ruihe Zichan and Xieyao Kexin Chuangye Touzi are the most recent investors.
Investor Name Lead Investor Funding Round
Ruihe Zichan Yes Series B
Xieyao Kexin Chuangye Touzi Series B
Ningbo Meishan Baoshuigang Wosheng Touzi Series A
Zhuhai Jinquan Jijin Guanli Youxian Gongsi Series A
Suzhou Gongye Yuanqu Bohe Chuangye Touzi Guanli Youxian Gongsi Angel